Section 1

Preview this deck

Histology of wet gangrenous necrosis

Front

Star 0%
Star 0%
Star 0%
Star 0%
Star 0%

0.0

0 reviews

5
0
4
0
3
0
2
0
1
0

Active users

0

All-time users

0

Favorites

0

Last updated

6 years ago

Date created

Mar 1, 2020

Cards (322)

Section 1

(50 cards)

Histology of wet gangrenous necrosis

Front

Liquefactive superimposed on coagulative

Back

dry gangrenous necrosis

Front

Ischemia

Back

Apoptosis

Front

Process of programmed cell death ATP-dependent Activate caspases (cytosolic proteases) -> cellular breakdown including: * cell shrinkage * chromatin condensation * membrane blebbing * formation of apoptotic bodies, which are then phagocytosed

Back

Bcl-2 overexpression

Front

Follicular Lymphoma Decrease caspase activation -> tumorigenesis

Back

Immune cell pathway of extrinsic apoptosis

Front

Cytotoxic T-cell release of perforin and granzyme B

Back

Fat necrosis seen in

Front

Enzymatic: scute pancreatitis (saponification of peripancreatic fat); Nonenzymatic: traumatic (eg, injury to breast tissue)

Back

Fibrinoid necrosis seen in

Front

necrosis of immune reactions (immune vasculitis/endocarditis); preeclampsia; malignant hypertension

Back

Pyknosis is a term used to describe a

Front

small, condensed, dark, fragmented nucleus

Back

extrinsic pathway of apoptosis

Front

Back

Liquefactive necrosis

Front

in brain, bacterial infections (abscesses), or wet gangrene

Back

caseous necrosis

Front

degeneration and death of tissue with a cheese-like appearance; Macrophages wall off the infecting microorganism -> granular debris

Back

Coagulative necrosis histology

Front

Cell outlines preserved but nuclei disappear; increase cytoplasmic binding of eosin dyes

Back

Coagulative necrosis results from?

Front

Sudden cut-off of blood supply to an organ Protein denature, enzymatic degradation

Back

Histology of dry gangrenous necrosis

Front

= coagulative

Back

liquefactive necrosis due to

Front

Neutrophils release lysosomal enzymes that digest the tissue; Enzymatic degradation first, then proteins denature

Back

Pyknosis/karyorrhexis

Front

Back

Bcl-2

Front

prevents cytochrome C release from mitochondria Keeps mtch outer membrane impermeable

Back

Intrinsic pathway factors

Front

Regulated by Bcl-2 family BAX and BAK are proapoptotic, Bcl-2 and Bcl-x are antiapoptotic

Back

liquefactive necrosis histology

Front

Early: cellular debris and macrophages Late: cystic spaces and cavitation (brain); Neutrophils and cell debris seen with bacterial infection

Back

Coagulative necrosis seen in

Front

Ischemia/infarcts in most tissues (except brain)

Back

Fat Necrosis Histology

Front

Outlines of dead cells without peripheral nuclei; Saponification of fat (combined with Ca2+) appears dark blue on H&E stain

Back

Fibrinoid necrosis

Front

Immune complexes combine with fibrin -> vessel wall damage (type III hypersensitivity reaction)

Back

Liquefactive necrosis occurs in the brain because:

Front

It is rich in hydrolytic enzymes and lipids

Back

Necrosis types:

Front

Coagulative Liquefactive Caseous Fat Fibrinoid Gangrenous

Back

Intrinsic mitochondrial pathway

Front

Back

Saponification

Front

When fat dies and fatty acids are released, they combine with Ca to produce chalky white deposits

Back

Apoptosis

Front

Back

Cell injury

Front

Back

cell injury reversible with oxygen

Front

CELL/mitochondrial swelling (low ATP-> lower activity of Na+/K+ and Ca2+ pumps); nuclear chromatin clumping, decreased glycogen, fatty change, ribosomal detachment (decrease protein synthesis) Membrane blebbing

Back

Ischemia

Front

an inadequate blood supply to an organ or part of the body, especially the heart muscles.

Back

Apoptosis histology

Front

Deeply eosinophilic cytoplasm; Basophilic nucleus Pyknosis Karyorhesis Cell membrane typically remains intact (unlike necrosis) DNA laddering (fragment in multiple of 180 bp) is a sensitive indicator

Back

fat necrosis due to

Front

Damaged cells release lipase to break down triglycerides, liberating fatty acids to bind Ca -> saponification

Back

Necrosis

Front

Enzymatic degradation and protein denaturation of cell due to exogenous injury -> intracellular components leak. Inflammatory process (unlike apoptosis)

Back

Karyorrhexis

Front

Fragmentation of nucleus Caused by endonuclease-mediated cleavage

Back

wet gangrenous necrosis

Front

Superinfection

Back

caseous necrosis

Front

Back

Fas-FasL interaction

Front

Last way of killing for CD8+ (apoptosis) "death receptor", finishes up and marks for death Thymic medullary negative selection

Back

coagulative necrosis

Front

Back

Gangrenous necrosis seen in

Front

Distal extremity and GI tract, after chronic ischemia

Back

Necrosis definition

Front

Death of a large group of cells followed by acute inflammation

Back

intrinsic pathway of apoptosis occurs

Front

occurs during embryogenesis, hormone induction, and atrophy Regulating factor is withdrawn from a proliferating cell population (eg, decreased IL-2 after a completed immunologic reaction) Also occurs after exposure to injurious stimuli (radiation, toxins, hypoxia)

Back

caseous necrosis

Front

TB Systemic fungi (eg, Histoplasma capsulatum), Nocardia

Back

Apoptotics pathways

Front

Intrinsic (mitochondrial) Extrinsic (death receptor)

Back

Ligand Receptor Interaction

Front

- Intracellular Receptors - Cell membrane receptors and membrane bound organelles - FasL binding to Fas (CD95) or TNF -a binding to its receptor

Back

liquefactive necrosis

Front

commonly results from ischemic injury to neurons and glial cells in the brain; Bacterial abscesses

Back

Fibrinoid necrosis histology

Front

Vessel walls are thick and pink

Back

Cell injury irreversible

Front

Nucleus: pyknosis, karyorrhexis, karyolysis; Increase mitochondrial permeability; Rupture of lysosomes and autolysis; Plasma membrane damage (degradation of membrane phospholipid) Cell death

Back

Fat necrosis

Front

Disruption of fat, fibrosis, giant cell formation, and inflammation

Back

extrinsic pathway of apoptosis

Front

death-receptor initiated 2 pathways: * ligand receptor interaction * immune cell

Back

defective Fas-FasL interactions →

Front

autoimmune disease (extrinsic apoptotic pathway necessary for T cell negative selection) Autoimmune lymphopriferative syndrome

Back

Section 2

(50 cards)

watershed areas of cerebral circulation

Front

Back

Red infarct

Front

Develops in tissues which have dual blood supplies (infarction) Happens with lung infarction

Back

P-selectin

Front

derived from Weibel-Palade bodies in venular endothelial cells Plateled and endothelial cells. Step 1 leukocyte extravasation

Back

Pale infarct

Front

Occur in solid tissues with a single blood supply

Back

Cellular component of inflammation

Front

Neutrophils extravasate from circulation to injured tissue to participate in inflammation through phagocytosis, degranulation, and inflammatory mediator release

Back

pale infarct

Front

Anemic; occur in solid tissues with SINGLE (end-arterial) blood supply like heart, kidney, spleen

Back

Extent of dystrophic calcification

Front

Tends to be localized (eg, calcific aortic stenosis) shows dystrophic calcification and thick fibrosis wall

Back

CD34, glyCAM-1

Front

addressin for L-selectin at lymph nodes

Back

VLA-4

Front

Expressed on activated T cells, guides T cells to site of infection by binding to VCAM-1

Back

ICAM-1

Front

- on APC or endothelium - binds LFA-1 on T cell CD54

Back

Sialyl-Lewis

Front

Adhesion molecules expressed on leukocytes that bind to selectins

Back

Most vulnerable neurons to hypoxic-ischemic insults

Front

Purkinje cells of cerebellum and pyramidal cells of the hypocampus and neocortex

Back

Etiology of dystrophic calcification

Front

2• to injury or necrosis

Back

metastatic calcification associated

Front

Predominantly in interstitial tissues of kidney, lung, gastric mucosa (these tissues lose acid quickly; increase pH favors Ca2+ deposition) Nephrocalcinosis of collecting ducts May lead to nephrogenic diabetes insipidus and renal failure

Back

CREST syndrome

Front

Calcinosis, Raynaud's, Esophageal dysmotility, Sclerodactyly, Telangiectasia

Back

PCA

Front

posterior cerebral artery

Back

Dystrophic calcification

Front

Back

MCA

Front

middle cerebral artery

Back

Steps of leukocyte extravasation

Front

Margination and rolling; Tight binding (adhesion₽); Diapedesis; Migration

Back

Step 1 in leukocyte extravasation:

Front

Margination and rolling; E-selectin; P-selection; GlyCAM-1; CD34; Sialyl-LewisX leukocytes; L selectin.

Back

CD11/CD18

Front

markers for integrins

Back

Heart most vulnerable region to hypoxia/ischemia

Front

Subendocardium (LV)

Back

Liver most vulnerable region to hypoxia/ischemia

Front

Area around central vein (zone III)

Back

Chronic inflammation characteristics

Front

Persistent destruction and repair. Associated with blood vessels proliferation, fibrosis. Granulomas. Outcome include scarring, amyloidosis, and neoplastic transformation.

Back

VCAM-1

Front

Expressed on endothelium of blood vessels in inflamed tissue, binds to VLA-4 on T cells CD106

Back

Dystrophic calcification Associate

Front

TB (lung, pericardium) and other granulomatous infection; Liquefactive necrosis of chronic abscesses; Fat necrosis; Infarcts; Thrombi; Schistosomiasis; Congenital CMV; Toxoplasmosis; Rubella; Psamomma bodies; CREST syndrome

Back

Psammoma bodies

Front

Meningiomas, papillary thyroid carc, mesothelioma, papillary serous carcinoma of endometrium/ovary

Back

metastatic calcification

Front

mineral deposits that occur in undamaged tissues due to hypercalcemia; Widespread extent ( metastatic calcification of alveolar walls in acute pneumonia)

Back

watershed areas

Front

areas between terminal branches of major arterial blood supplies where blood supply does not overlap. These areas are susceptible to ischemia from hypoperfusion

Back

Mac-1

Front

Integrin- heterodimer- one chain is CD18-the 2 integrin chain, on monocytes and macrophages

Back

Etiology of metastatic calcification

Front

2• to hypercalcemia (eg, 1• hyperparathyroidism; sarcoidosis; hypervitaminosis D) or high calcium-phosphate product levels (eg, chronic renal failure with 2• hyperparathyroidism, long-term dialysis, calciihylaxis, multiple myeloma)

Back

Dystrophic calcification

Front

calcification of damaged tissue; normal serum calcium;

Back

Vascular component of inflammation

Front

Increased vascular permeability, vasodilation, endothelial injury

Back

Leukocyte extravasation occurs predominately where?

Front

Extravasation predominantly occurs at postcapillary venules.

Back

acute inflammation cells

Front

Neutrophils, eosinophils, atb (pre-existing), mast cell, and basophil mediated.

Back

caseous necrosis histology

Front

Fragmented cells and debris surrounded by lymphocytes and macrophages

Back

E-selectin

Front

Selectin molecule on endothelial cells; Unregulated by TNF and IL-1; Step 1 of leukocyte extravasation.

Back

ACA

Front

anterior cerebral artery

Back

Serum Ca2+ levels in metastatic calcification

Front

Not normocalcemic

Back

Serum Ca2+ levels in patient with dystrophic calcification

Front

Normocalcemic

Back

Subsequent infarction in brain

Front

ACA/MCA/PCA boundary areas

Back

Acute inflammation characteristics

Front

Rapid onset (seconds, minutes) - short duration (minutes, days). Outcome: complete resolution, abscess formation, or progression to chronic inflammation

Back

Granuloma

Front

Nodular collections of epithelioid macrophages (abundant pink cytoplasm) with surrounding multinucleated giant cells and lymphocytes.

Back

VCAM-1 and ICAM-1 aid in the (x) of leukocyte diapedesis

Front

Firm adhesion (x)

Back

LFA-1

Front

molecule expressed by leukocyte that assists in tight-binding stage of leukocyte extravasation

Back

Types of infarcts

Front

Red Pale

Back

Margination and rolling is defective in which disorder(s)?

Front

Leukocyte adhesion deficiency type 2 (decreased Sialyl-Lewis)

Back

red infarct

Front

Hemorrhagic; Occurs in venous occlusion and tissues with multiple blood supplies such as liver, lung, intestine, tested; Reperfusion (after angioplasty) -> injury due to damage by free radicals

Back

Chronic inflammation cells

Front

Mononuclear cell (monocytes/macrophages, lymphocytes, plasma cells) and fibroblast mediated.

Back

Inflammation characterized by....

Front

redness (rubor), heat (calor), swelling (tumor), pain (dolor) and functio laesa (loss of function)

Back

Section 3

(50 cards)

Hypertrophic scar

Front

A raised scar characterized by excess collagen. (III) Parallel organization of collagen Confined to borders of original wound Infrequent No predisposition

Back

Sarcoidosis Dx

Front

Chest Xray, Lesion Biopsy ( Better sample is Lung. Do not take biopsy from erythema Nodosum) Noncaseating granulomas

Back

ERBB1 (EGFR)

Front

Adenocarcinoma of Lung

Back

exudate

Front

cellular (cloudy), protein rich (>2.9 g/dL), high LDH (vs serum). Due to: lymphatic obstruction (chylous), inflammation/infection; malignancy.

Back

Granulomas formation

Front

Th1 cells secrete IFN-y, activating macrophages. TNF-a from macrophages induces and maintains granuloma formation. Associated with hypercalcemia due to calcitriol (1,25 -[OH]2 vitamin D3) production. Caseating necrosis is more common with an infection etiology.

Back

VEGF

Front

stimulates angiogenesis

Back

Congo red stain

Front

Amyloid stains brick red and displays apple green birefringence with polarized light

Back

Autoinflammatory granulomatous disease

Front

Sarcoidosis Crohn disease Primary biliary cirrhosis Subacute (de Quervain/granulomatous) thyroiditis Granulomatosis with polyangiitis (Wegener) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) Giant cell (temporal) arteritis Takayasu arteritis

Back

TGF-b

Front

Angiogenesis, fibrosis, cell cycle arrest

Back

Proliferative phase of healing cells

Front

Fibroblasts, myofibroblasts, endothelial cells, keratinocytes, macrophages.

Back

low ESR

Front

CHF, low plasma protein, polycythemia, sickle cell, microcytosis, hypofibrinogenemia.

Back

Anti-TNF drugs

Front

As a side effect can cause sequestering granulomas to break down, leading to disseminated disease. Always test for Karen TB before starting anti-TNF therapy.

Back

Granulomatous disease from foreign material

Front

Berylliosis Talcosis Hypersensitivity pneumonitis

Back

Diapedesis is the

Front

migration of white blood cells from the blood out to the tissues.

Back

Bacterial granulomatous disease

Front

Mycobacterium; Bartonella henselae (cat scratch disease); Listeria monocytogenes (granulomatous infantiseptica); Treponema pallidum (3• Syphilis)

Back

Light criteria

Front

Dx analysis comparing serum and pleural fluid protein and LDH levels.

Back

Amyloid deposits visualization by polarized light

Front

Apple-green birefringence

Back

effusion

Front

outpouring

Back

Amyloidosis

Front

Abnormal aggregation of proteins (or their fragments) into b-pleated linear sheets -> insoluble fibrils -> cellular damage and apoptosis.

Back

Pleural effusion is exudative if >= 1 of the following criteria is met:

Front

*Pleural effusion protein/serum ratio > 0.5 * Pleural effusion LDH/serum LDH ration > 0.6 * Pleural effusion LDH > 2/3 of the upper limit of normal for serum LDH

Back

PECAM-1

Front

CD31

Back

Oxygen toxicity examples

Front

Retinopathy of premature (abnormal vascularization), bronchopulmonary dysphasia, reperfusion injury after thrombolytic therapy

Back

remodeling phase of healing

Front

Fibroblasts Type III collagen replaced by type I collagen, Increase tensile strength of tissue. Delayed wound healing in zinc deficiency.

Back

free radical injury

Front

damage to cells resulting from reactive oxygen species via: Membrane lipid peroxidation; Protein modification; DNA breakage

Back

CHF (congestive heart failure)

Front

heart is unable to pump its required amount of blood

Back

Keloid scar

Front

Raised and moves beyond edges of wound (genetic and reoccurring) Claw-like projection typically on earlobes, face, upper extremities. Frequent reccurence. Higher incidence in ethnic groups with darker skin, Desorganized types I and III collagen

Back

Granulomas

Front

Back

Hypertrophic scar

Front

Back

Proliferative phase of healing characteristics:

Front

Deposition of granulation tissue and type III collagen, angiogenesis, epithelial cell proliferation, dissolution of clot, wound contraction (mediated by myofibroblasts). Delayed wound healing in vit C deficiency and cooper deficiency.

Back

Free radicals can be eliminated by

Front

Scavenging enzymes (catalase, superoxide dismitase, glutathione peroxidase); Spontaneous decay; Antioxidants (A,C,E); Certain metal carrier proteins (transferrin, ceruloplasmin).

Back

EGF

Front

epidermal growth factor Stimulate cell growth via tyrosine kinases (eg, EGFR/ErbB1)

Back

PECAM-PECAM binding produces what effect?

Front

Adhesion for transmigration

Back

Metalloproteinases

Front

Tissue remodeling

Back

ROS sources:

Front

Radiation exposure (cancer therapy) Mtb of drugs (phase I) Redox reaction; Nitric oxide (inflammation); Transition metals; WBC (neutrophils, macrophages) oxidative burst.

Back

Transudate

Front

Hypocellular (clear), poor protein (<2.5 g/dL), low LDH (vs serum). Due to: High hydrostatic pressure (eg, HF, Na+ retention) Low oncotic pressure (eg, cirrhosis, nephrotic syndrome)

Back

Migration

Front

4 step of leukocyte extravasation. WBC travels through interstitium to site of injury or infection guided by chemotaxis signals

Back

Erythrocytes sedimentation rate (ESR)

Front

Products of inflammation (eg, fibrinogen) coat RBCs and cause aggregation. The denser RBC aggregates fall at a faster rate within a pipette tube. Often co-tested with CRP levels.

Back

Tissue mediators

Front

PDGF, FGF, EGF, TGF-β, Metalloproteinases, VEGF

Back

C5a, IL8, LTB4, kallikrein, PAF

Front

important neutrophil chemotactic agents

Back

inflammatory phase of healing

Front

Platelets, neutrophils, macrophages; Clot formation, increase vessel permeability and neutrophil migration into tissues; Macrophages cleat debris 2 days later.

Back

Phase of wound healing:

Front

Inflammatory (up to 3 days after wound); Proliferative (day 3-weeks after wound); Remodeling (1 week-6+ months after wound)

Back

ROS drug/chemical toxicity:

Front

Carbon tetrachloride and acetaminophen overdose (hepatotoxicity)

Back

Keloid scar

Front

Back

high ESR

Front

Most anemias; Infection; Inflammation (eg, giant cell [temporal] arteritis, polymyalgia rheumatica); Cancer (eg, metastases, multiple myeloma), Renal Disease (end-stage or nephrotic syndrome); Pregnancy

Back

Parasitic granulomatous disease

Front

Schistosomiasis

Back

Oxygen toxicity symptoms

Front

VENTIAC V ertigo E uphoria N ausea T innitus I mpaired judgement A LOC (Altered LOC) C onvulsions

Back

Fungal granulomatous disease

Front

Endemic mycoses (eg, histoplasmosis)

Back

FGF

Front

Stimulates angiogenesis Fibroblast growth factor

Back

PDGF

Front

Induces vascular remodeling and smooth muscle cell migration; Stimulates fibroblast growth for collagen synthesis; Secreted by activated platelets and macrophages.

Back

Amyloid deposits by H&E

Front

Back

Section 4

(50 cards)

Epithelial benign tumor

Front

Adenine, papilloma

Back

Hypertrophy

Front

Increase in cell size

Back

bone benign tumor

Front

osteoma

Back

Connective tissue benign tumor

Front

Fibroma

Back

Carcinoma

Front

a malignant tumor that occurs in epithelial tissue

Back

ESRD

Front

end-stage renal disease

Back

Heritable amyloidosis

Front

Heterogeneous group of disorders, including familial amyloid polyneuropathies due to transthyretin gene mutation.

Back

Hamartomas

Front

Disorganized overgrowth of tissue in their native location (eg, Peutz-Jeghers polyps)

Back

Neoplastic progression dysplasia

Front

Abnormal proliferation of cell with loss of size, shape, and orientation (eg, koilocytic change)

Back

Tumor Grading

Front

Stage generally has more prognostic value than grade

Back

Colon most vulnerable region to hypoxia/ischemia

Front

Splenic flexure, rectum

Back

AL amyloid (primary)

Front

Deposition of protein from Ig Light chains. Can occur as a plasma cell disorder or associated with multiple myeloma. Often affect multiple organ systems, including renal (nephrotic syndrome), cardiac (restrictive cardiomyopathy, arrhythmia), hematologic (easy bruising, splenomegaly), GI (hepatomegaly), neurologic (neuropathy)

Back

poorly differentiated tumors

Front

recur more rapidly after diagnosis, higher short term mortality Often more aggressive; Look almost nothing like their tissue of origin

Back

blood vessels benign tumor

Front

hemangioma

Back

Hyperplasia

Front

increase in number of cells May be a risk factor for future malignancy (eg, endometrial hyperplasia) but not considered premalignant.

Back

Choristoma

Front

normal tissue aberrant tissue location; pancreatic tissue stomach wall

Back

Tumor stage

Front

Degree of localization/spread based on site and size of 1• lesion, spread to regional lymph nodes, presence of metastases. Based on clinical (c) or pathology (p) findings.

Back

invasive carcinoma

Front

Cells have invaded basement membrane using collagenases and hydrolases (metalloproteinases). Cell-cell contacts lost by inactivation of E-cadherin.

Back

Neoplasia

Front

Uncontrolled, clonal proliferation of cells. Can be benign or malignant.

Back

metastasis

Front

spread to distant organs via lymphatics or blood.

Back

Epithelial malignancy

Front

Adenocarcinoma Papillary carcinoma

Back

Atrophy

Front

Decrease in tissue mass due to decrease in size or/and number of cells. Causes include disuse, denervation, loss of blood supply, loss of hormonal stimulation, poor nutrition.

Back

smooth muscle benign tumor

Front

leiomyoma

Back

Seed and soil theory

Front

Seed= tumor embolus Soil = target organ is often the first-encountered capillary bed (liver, lungs, bone, brain, etc)

Back

Dialysis-related amyloidosis

Front

Fibrils composed of b2-microglobulin in patients with ESRD and/or long term dialysis. May present as carpal tunnel syndrome.

Back

organ specific amyloidosis?

Front

Single organ; Alzheimer disease due to deposition of b-amyloid protein cleaved from amyloid precursor protein (APP). IAPP is commonly seen in DM2 and is caused by deposition of amylin in pancreatic islet. Isolated atrial amyloidosis due to atrial natriuretic peptide is common in normal aging and can predispose to increased risk of atrial fibrillation. Amyloid deposition to ventricular endomyocardium in restrictive cardiomyopathy. Calcitonin deposition in tumor cells in medullary carcinoma of the thyroid.

Back

Kidney most vulnerable region to hypoxia/ischemia

Front

Straight segment of proximal tubule (medulla); Thick ascending limb (medulla)

Back

Differentiation

Front

The degree to which a tumor resembles the normal tissue from which it arose

Back

fat benign tumor

Front

lipoma

Back

Malignant tumor

Front

Poor differentiation, erratic growth, local invasion, metastasis, decrease apoptosis. Upregulation of telomerase prevents chromosome shortening and cell death.

Back

Peutz-Jeghers syndrome

Front

GI tract polyposis, mucocutaneous pigmentation -estrogen secreting tumor: precocious puberty

Back

Metaplasia

Front

Replacement of one cell type with another. Usually due to exposure to an irritant, such as gastric acid or cigarette smoke. Reversible if the irritant is removed but may undergo malignant transformation with persistent insult (eg, Barrett esophagus-> esophageal adenocarcinoma)

Back

IAPP

Front

Islet amyloid polypeptide

Back

Koilocytes

Front

Seen in HPV. Dysplastic squamous cervical cells with nuclear enlargement and hyperchromasia

Back

AA amyloid (secondary)

Front

Seen with chronic inflammatory conditions such as RA, IBD, spondylarthropathy, familial Mediterranean fever, protracted infection. Fibrils composed with serum Amyloid A. Often multisystemic.

Back

Sarcoma

Front

Cancer of the supportive tissues (mesenchymal), such as bone, cartilage, and muscle.

Back

Non-neoplastic malformations:

Front

Hamartoma Choristoma

Back

benign tumor

Front

Well differentiated, well demarcated, low mitotic activity, no metastasis, no necrosis.

Back

Anaplasia

Front

Complete lack of differentiation of cells in a malignant neoplasm

Back

Hallmarks of cancer

Front

Eight fundamental changes in cell biology that lead to malignant transformation: Evasion of apoptosis; Growth signal self-sufficiency; Anti-growth Signal insensitivity; Sustained angiogenesis; Limitless replicative potential; Tissue invasion; Metastasis.

Back

Tumor grade

Front

Degree of cellular differentiation and mitotic activity on histology. Range from low grade (well differentiated) to high grade (poorly differentiated, undifferentiated, anaplastic)

Back

Dysplasia

Front

Disordered cell growth, most often referring to proliferation of precancerous cells. Non-neoplastic cell growth. Term used only with epithelial cells. Mild dysplasia is usually reversible, severe dysplasia usually progresses to carcinoma in situ.

Back

Neoplastic progression: normal state, before anything goes wrong

Front

Normal cells w/ basal --< apical differentiation.

Back

carcinoma in situ

Front

noninvasive cancer located in a small area of the epithelial layer. Not invaded the intact basement membrane. Increase nuclear: cytoplasmic ratio and clumped chromatin. Neoplastic cells encompass entire thickness.

Back

Meckel's diverticulum

Front

Gastric tissue in distal ileum

Back

Well-differentiated tumors

Front

(often less aggressive) closely resemble their tissue of origin.

Back

TNM staging system

Front

T = size of T umor / invasiveness N = N ode involvement M = M etastases Each TNM factor has independent prognostic value; N and M are often most important

Back

Lipofuscin

Front

A yellow-brown "wear and tear" pigment associated with normal aging. Formed by oxidation and polymerization of autophagocytosed organellar membranes. Autopsy of elderly person will reveal deposits in heart, colon, liver, kidney, eye, atc.

Back

Striated muscle benign tumor

Front

Rhabdomyoma

Back

Age-related (senile) systemic amyloidosis

Front

Due to deposition of normal ( wild-type) transthyretin (TTR) predominantly in cardiac ventricles. Slower progression of cardiac dysfunction relative to AL amyloidosis.

Back

Section 5

(50 cards)

Cutaneous manifestation of paraneoplastic syndrome

Front

Acanthosis nigricans; Sign of Leser-Trélat

Back

Anti-NMDA receptor encephalitis mechanism

Front

Psychiatric disturbance, memory deficits, seizures, dyskinesias, autonomic instability, language disfunction.

Back

blood vessels malignant tumor

Front

angiosarcoma

Back

bone malignant tumor

Front

osteosarcoma

Back

Endocrine manifestation of paraneoplastic syndrome

Front

Hypercalcemia; Cushing syndrome; Hyponatremia (SIADH)

Back

SIADH

Front

syndrome of inappropriate antidiuretic hormone Hyponatremia Small cell lung cancer

Back

Melanocyte benign tumor

Front

Nevus/mole

Back

The most common cancer

Front

Skin cancer Basal > squamous >> melanoma

Back

Opsoclonus-myoclonus ataxia syndrome

Front

"Dancing eyes, dancing feet" Neuroblastoma (children); Small cell lung cancer (adults)

Back

Paraneoplastic encephalomyelitis

Front

Atb against Hu atg in Neurons. Small cell lung cancer

Back

Anti-NMDA receptor encephalitis seen with what condition?

Front

Ovarian teratoma

Back

Cancer mortality women

Front

lung → breast → colorectal

Back

Cancer mortality men

Front

lung → prostate → colorectal

Back

Paraneoplastic cerebellar dyndrome

Front

Atb again atg in Purkinje cells. Small cell lung cancer (anti-Hu); Gynecologic and breast cancer (anti-Yo), Hodgkin lymphoma (anti-Tr).

Back

Cancer incidence women

Front

breast → lung → colorectal

Back

opsoclonus-myoclonus syndrome

Front

non-rhythmic conjugate eye movement and myoclonus associated with neuroblastoma

Back

Smooth muscle malignant tumor

Front

Leiomyosarcoma

Back

dyskinesia

Front

difficult or painful movement

Back

Neuromuscular manifestation of paraneoplastic syndrome

Front

Anti-NMDA receptor encephalitis; Opsoclonus-myoclonus ataxia syndrome; Paraneoplastic cerebellar degeneration; Paraneoplastic encephalomyelitis; Lambert-Eaton myasthenic Syndrome; Myasthenia gravis.

Back

Pure red cell aplasia associated with

Front

Anemia with low reticulocytes; thymoma, lymphocytic leukemias, parvovirus B19 ifxn.

Back

Blood cells malignancy

Front

Leukemia Lymphoma

Back

Connective tissue malignant tumor

Front

Fibrosarcoma

Back

Sign of Leser-Trelat

Front

Sudden appearance of multiple seborrheic keratoses that may be associated with internal malignancy GI adenocarcinoma and other visceral malignancies

Back

Acanthosis nigricans associated

Front

Gastric adenocarcinoma and other visceral malignancies (but more commonly associated with obesity and insulin resistance)

Back

Lambert-Eaton

Front

Ig against Ca channels -> decrease Ach -> muscle weakness that improves w/ repetition

Back

Trousseau syndrome

Front

migratory spf thrombophlebitis; Thymoma

Back

myasthenia gravis

Front

Antibodies against postsynaptic ACh receptors at NMJ Thymoma

Back

BCR-ABL

Front

Oncogene Tyrosine kinase CML, ALL

Back

Hypercalcemia sign

Front

PTHrP: Squamous cell carcinomas of lung, head, neck; Renal, bladder, breast, ovarian carcinomas. high 1,25-(OH)2 vitamin D3 (calcitriol): Lymphoma

Back

Cancer mortality children

Front

Leukemia > brain and CNS > neuroblastoma

Back

Cancer incidence men

Front

prostate → lung → colorectal

Back

Good syndrome (hypogammaglobulinemia)

Front

Thymoma

Back

Oncogenes

Front

a gene that causes normal cells to change into cancerous tumour cells. Need damage only one allele for disease expression

Back

Cancer incidence children (0-14)

Front

Leukemia > brain and CNS > neuroblastoma

Back

Hematologic manifestation of paraneoplastic syndrome

Front

Polycythemia; Pure red cell aplasia; Good syndrome; Trousseau syndrome; Nombacterial thrombotic (marantic) endocarditis.

Back

Lambert-Eaton myasthenic syndrome

Front

Antibodies against presynaptic (P/Q-type) calcium channels at NMJ Small cell lung cancer

Back

fat malignant tumor

Front

liposarcoma

Back

ALK

Front

Oncogene Receptor tyrosine kinase Lung adenocarcinoma

Back

second leading cause of death in the US

Front

cancer

Back

first leading cause of death in U.S.

Front

heart disease

Back

autonomic instability

Front

NMS, serotonin syndrome

Back

Cushing's syndrome

Front

High cortisol due to excess ACTH. Small cell lung cancer

Back

Striated muscle malignant tumor

Front

Rhabdomyosarcoma

Back

Nonbacterial thrombotic (marantic) endocarditis

Front

Deposition of sterile platelet thrombi on heart valves Adenocarcinomas, especially pancreatic

Back

melanocyte malignant

Front

Melanoma

Back

Acanthosis nigricans

Front

Hyperpigmented velvety plaques in axilla and neck

Back

Polycythemia

Front

High EPO Renal cell carcinoma, hepatocellular carcinoma, hemangioblastoma, pheochromocytoma, leiomyoma.

Back

paraneoplastic syndrome

Front

tumor cells release substances that affect neurological function and may have hormonal effects

Back

NMS

Front

neuroleptic malignant syndrome

Back

myoclonus

Front

the sudden, involuntary jerking of a muscle or group of muscles

Back

Section 6

(50 cards)

TSC1

Front

Hamartin protein Tuberous sclerosis tumor suppressor genes

Back

c-KIT

Front

Cytokine receptor Gastrointestinal stromal tumor (GIST) Oncogene

Back

HTLV-1

Front

Adult T-cell leukemia/lymphoma

Back

aromatic amines (benzidine, 2-naphthylamine)

Front

transitional cell carcinoma Bladder

Back

Vinyl chloride

Front

angiosarcoma of liver

Back

BRCA1/BRCA2

Front

Breast and ovarian cancer, pancreatic cancer DNArepair protein tumor suppressor genes

Back

carbon tetrachloride

Front

centrilobular necrosis, fatty change (liver)

Back

WT1

Front

Tumor Suppressor Gene Associated Disease: Wilms Tumor (Chr. 11) Gene Product: not listed (TF that regulates urogenital development)

Back

JAK2

Front

Tyrosine kinase Chronic myeloproliferative disorders Oncogene

Back

Liver fluke (Clonorchis sinensis)

Front

Cholangiocarcinoma

Back

c-MYC

Front

Transcription factor Burkitt lymphoma Oncogene

Back

TSC2

Front

Tuberin protein Tuberous sclerosis tumor suppressor genes

Back

NF1

Front

tumor supressor: inc risk, need 2 RAS GTPas activating protein (neurofibromin) NF type 1

Back

BCL-2

Front

Oncogene Antiapoptotic molecule (inhibits apoptosis) Follicular and undifferentiated lymphomas

Back

Serum tumor marker

Front

Shouldn't be used as the 1• tool for cancer Dx or screening. Used to monitor tumor reccurence and response to therapy. Definitive Dx via biopsy

Back

Psammoma bodies means

Front

Laminated, concentric spherules with dystrophic calcification.

Back

PTEN

Front

Tumor Suppressor (2 hit) Breast cancer, prostate cancer, endometrial cancer Tyrosine phosphatase of PIP3 (eg, protein kinase B [AKT] activation)

Back

HER2/neu (c-erbB2)

Front

Gene product: Tyrosine kinase receptor Associated tumor(s): Breast, ovarian, & gastric carcinomas Oncogene

Back

KRAS

Front

GTPase Colon cancer, lung cancer, pancreatic cancer Oncogene

Back

tumor suppressor genes

Front

code for proteins that inhibit the cell cycle and promote apoptosis Both alleles must be lost for expression disease

Back

Nitrosamines (smoked foods)

Front

Organ: Stomach Impact: Gastric cancer

Back

EBV associated malignancies? (x3)

Front

Nasopharyngeal carcinoma, Burkitt lymphoma, CNS lymphoma (in ID); Hodgkin lymphoma.

Back

MEN1

Front

AD Tumor Suppressor (2 hit) Menin Parathyroid, pancreatic endocrine, and pituitary tumors

Back

MYCN

Front

Transcription factor Neuroblastoma Oncogene

Back

MYCL1

Front

Transcription factor Lung tumor Oncogene

Back

Aflatoxins (Aspergillus)

Front

Hepatocellular carcinoma

Back

Oncogenic microbes

Front

EBV; HBC,HCV; HHV-8; HPV; H pylori; HTLV-1; Liver fluke (Clonorchis sinensis); Schistosoma haematobium

Back

Alkylating agents

Front

Leukemia/lymphoma this can be a side effect of chemotherapy

Back

PSaMMoma bodies

Front

Papillary carcinoma of thyroid; Serous papillary cystadenocarcinoma of ovary. Meningioma Malignant Mesothelioma

Back

cigarette smoke

Front

Transitional cell carcinoma (Bladder); Cervical carcinoma; Squamous cell carcinoma/ adenocarcinoma (esophagus); Renal cell carcinoma; Squamous cell carcinoma (larynx); Squamous cell carcinoma and small cell carcinoma (lungs); Pancreatic adenocarcinoma.

Back

HBV, HCV

Front

MC risk factors for hepatocellular carcinoma

Back

DCC

Front

Tumor Suppressor (2 hit) Colon cancer DCC—Deleted in Colon Cancer

Back

Li-Fraumeni syndrome SBLA

Front

Sarcoma Breast Leukemia Adrenal gland

Back

NF2

Front

AD Tumor Suppressor (2 hit) NeuroFibromatosis type 2 Merlin (schwannomin) protein

Back

HPV

Front

cervical, penis, and anorectal squamous cancers (16,18) Head and neck cancer

Back

Rb

Front

tumor suppressor gene Inhibits E2F; blocks G1->S phase RetinoBlastoma, osteosarcoma

Back

Asbestos

Front

Bronchogenic carcinoma > mesothelioma

Back

RET

Front

Tyrosine kinase receptor; MEN2A and 2B, medullary thyroid cancer, and Hirschsprung's Oncogene

Back

Arsenic

Front

Angiosarcoma (Liver) lung cancer squamous cell carcinoma (skin)

Back

CDKN2A - cyclin-dependent kinase inhibitor 2A

Front

encodes both P16 and P14 (blocks G1 ->S phase -> plays significant role in development of melanoma as well as SCC, pancreatic cancer tumor suppressor genes

Back

VHL

Front

inhibits hypoxia inducible factor 1a Von Hippel-Lindau disease tumor suppressor genes

Back

APC

Front

Colorectal cancer (associated with FAP) Negative regulator of b-catenin/WNT pathway tumor suppressor genes

Back

Ethanol

Front

Squamous cell carcinoma (esophagus); Hepatocellular carcinoma

Back

ionizing radiation

Front

papillary thyroid carcinoma

Back

BRAF

Front

Produces serine/threonine kinase associated with melanoma, non-Hodgkin lymphoma, papillary thyroid carcinoma Oncogene

Back

Schistosoma haematobium

Front

Bladder cancer (squamous cell)

Back

DPC4/SMAD4

Front

Tumor Suppressor (2 hit) Pancreatic cancer DPC—Deleted in Pancreatic Cancer

Back

TP53

Front

tumor suppressor gene P53, activates p21, blocks G1->S phase Most human cancers, Li-Fraumeni syndrome (multiple malignancies at early age)

Back

HHV-8

Front

Kaposi sarcoma

Back

Radon

Front

Lung cancer (2nd leading cause after cigarette smoke)

Back

Section 7

(22 cards)

Brain metastases

Front

50% of brain tumor are from metastases. Commonly seen as multiple well-circumscribed tumors at gray/white matter junction.

Back

Liver metastasis

Front

Colon>>stomach>pancreas Liver and lung are the most common sites of metastasis after the regional lymph nodes

Back

CEA

Front

carcinoembryonic antigen. Very nonspecific. Major associations: colorectal and pancreatic cancers; Minor associations: gastric, breast, medullary thyroid carcinomas. Serum marker

Back

Calcitonin

Front

Medullary thyroid carcinoma Alone and in MEN2A, MEN2B, Serum marker

Back

Brain metastatic tumors are most likely from what?

Front

Lung tumors (40%) - often small cell, squamous, and adenocarcinoma in origin

Back

Bone metastases

Front

Prostate,breast > lung, thyroid, kidney. >> 1• bone tumors (eg, multiple myeloma, lytic). Breast (mixed) Lung (lytic) Thyroid (lytic) Kidney (lytic) Prostate (blastic) Predilection for axial skeleton.

Back

CA 125 tumor marker

Front

Ovarian Cancer

Back

Alkaline phosphatase

Front

Metastases to bone, liver, Paget's disease of bone, seminoma (placental ALP) Must exclude hepatic origin by checking LFTs and GGT levels

Back

cachexia

Front

Weight loss, muscle atrophy, fatigue that occur in chronic disease (cancer, AIDS, heart failure, COPD) Mediated by TNF, IFN-y, IL-1, IL-6

Back

Brain metastatic tumors come from

Front

Lung > breast > melanoma, colon, kidney

Back

LFTs (Abbreviation)

Front

Liver Function Tests: AST, SGOT, ALT, SGPT

Back

a-fetoprotein

Front

Tumor marker seen in hepatocellular carcinomas and testicular cancers; Hepatoblastoma, Yolk sac (endodermal sinus) tumor, mixed germ cell tumor.

Back

CA 15-3/CA 27-29

Front

breast Serum marker

Back

PSA

Front

prostate-specific antigen Prostate cancer. Can be elevated in BPH and prostatitis. Surveillance marker for reccurence Disease after prostatectomy.

Back

Common metastases

Front

Most sarcomas spread hematogenously; Most carcinomas spread via lymphatics. But 4! Hematogenously! Follicular thyroid carcinoma, Choriocarcinoma, Renal cell carcinoma, Hepatocellular carcinoma.

Back

Chromogranin

Front

Neuroendocrine tumors/carcinoid Serum marker

Back

B-hCG

Front

hydatiform mole, choriocarcinomas, gestational trophoblastic tumors, testicular cancer, mixed germ cell tumor. Produced by syncytiotrophoblasts of the placenta

Back

a-fetoprotein (AFP)

Front

Normally made by fetus. Transiently elevates in pregnancy. High levels associated with neural tube and abdominal wall defects, Low levels associated with Down syndrome

Back

CA 19-9

Front

Pancreatic adenocarcinoma Serum marker

Back

Four Carcinomas Route Hematogenously

Front

Follicular thyroid carcinoma; Choriocarcinoma; Renal cell carcinoma; Hepatocellular carcinoma

Back

P-glycoprotein

Front

multi-drug resistant protein 1. Classically seen in adrenocortical carcinoma but also expressed in some cancer cells (colon, liver). Used to pump out toxins, including chemotherapeutic agents (one mechanism of low responsiveness or resistance to Chemotherapy)

Back

GGT

Front

gamma-glutamyl transferase

Back